Article thumbnail

Liver Cancer Stem Cells

By Sameh Mikhail and Aiwu Ruth He

Abstract

Hepatocellular carcinoma is the most common primary malignancy of the liver in adults. It is also the fifth most common solid cancer worldwide and the third leading cause of cancer-related death. Recent research supports that liver cancer is a disease of adult stem cells. From the models of experimental hepatocarcinogenesis, there may be at least three distinct cell lineages with progenitor properties susceptible to neoplastic transformation. Identification of specific cell surface markers for each of the liver cell types, production of corresponding monoclonal antibodies and cell sorting techniques have together revolutionized the characteristics of normal stem cells. In hepatocarcinogenesis, multiple signaling transduction pathways, important for stem cell proliferation and differentiations, are deregulated. Strategies are being developed to identify and characterize the liver cancer stem cells. Targeting liver cancer stem cells may bring hope to curing hepatocellular carcinoma

Topics: Review Article
Publisher: SAGE-Hindawi Access to Research
OAI identifier: oai:pubmedcentral.nih.gov:3170823
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2005). A l t e k r u s e ,K .A .M c G l y n n ,a n dM .E .R e i c h m a n , “Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to
  2. (2006). Activation of the hedgehog pathwayinhumanhepatocellularcarcinomas,”Carcinogenesis,
  3. (2010). Annual report to the nation on the status of cancer, 1975–2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates,”
  4. (2004). B o s c h ,J .R i b e s ,M .D i a z ,a n dR .C l e r i e s ,“ P r i m a r yl i v e r cancer: worldwide incidence and trends,”
  5. (1999). B.E.Petersen,W.C.Bowen,K.D.Patreneetal.,“Bonemarrow as apotentialsourceofhepaticoval cells,”
  6. (2004). Bone marrow engraftment in a rodent model of chemical carcinogenesis but no role in the histogenesis of hepatocellular carcinoma,”
  7. (2008). C-kit inhibition by imatinib mesylate attenuates progenitor cell expansion and inhibits liver tumor formation in mice,”
  8. (2010). CA: A Cancer Journal for Clinicians,v o l .6 0 ,n o .5 ,p p .
  9. (2003). Caught up in a Wnt storm: Wnt signaling in cancer,”
  10. (2002). D u m b l e ,E .J .C r o a g e r
  11. (2007). de Reynies et al., “Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets,”
  12. (2008). Down-regulation of Sonic hedgehog signaling pathway activity is involved in 5-fluorouracil-induced apoptosis and motility inhibition
  13. (2006). Dysregulation of the Hedgehog pathway in human hepatocarcinogenesis,”
  14. (2004). e p o u r c e l e t
  15. (1975). Effect of a single treatment with the alkylating carcinogens dimethylnitrosamine, diethylnitrosamine and methyl methanesulphonate, on liver regenerating after partial hepatectomy.
  16. (2008). EpCAM and alphafetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma,”
  17. (2009). EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features,”
  18. (2010). Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications,”
  19. (2003). Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells,”
  20. (2002). Expression and prognostic roles of beta-catenin in hepatocellular carcinoma: correlation with tumor progression and postoperative survival,”
  21. (2004). Focal nodular hyperplasia with concomitant hepatocellular carcinoma: a case report and clonal analysis,”
  22. (2000). Functions of mammalian Smad genes as revealed by targeted gene disruption in mice,” C y t o k i n ea n dG r o w t hF a c t o rR e v i e w s ,
  23. (2002). Genetic analysis of the mammalian transforming growth factor-beta superfamily,”
  24. (2003). Hepatic ‘stem cell’ malignancies in adults: four cases,”
  25. (2002). Hepatic progenitor cells in human liver diseases,”
  26. (2003). Ianus et al., “Regeneration of hepatocyte ‘buds’ in cirrhosis from intrabiliary stem cells,”
  27. (2007). Identification and characterization of tumorigenic liver cancer stem/progenitor cells,”
  28. (2008). Identification of local and circulating cancer stem cells in human liver cancer,”
  29. (2001). J.TaipaleandP.A.Beachy,“TheHedgehogandWntsignalling pathways in cancer,”
  30. (2004). Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells,” Hepatology,v o l .3 9 ,n o .6 ,p p .
  31. (2009). Liver stem cells and hepatocellular carcinoma,”
  32. (2003). Mouse models to study the interaction of risk factors for human liver cancer,”
  33. (1993). Non-linearity of neoplastic conversion induced in rat liver by low exposures to diethylnitrosamine,”
  34. (2004). Oval cells compensate for damage and replicative senescence of mature hepatocytes in mice with fatty liver disease,”
  35. (2008). Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and
  36. (1986). s u m i ,T .A r i t a k a ,M .A r i ie ta l . ,“ C l o n a lo r i g i no fh u m a n hepatoma determined by integration of hepatitis
  37. (1997). Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes,”
  38. (2006). Side population purified from hepatocellular carcinoma cells harbors cancer stem celllike properties,”
  39. (2006). Signal transduction cascades and hepatitis
  40. (2008). Significance of CD90+ cancer stem cells in human liver cancer,”
  41. (2010). Targeting Notch to target cancer stem cells,”
  42. (2000). TGFbeta signaling in growth control, cancer, and heritable disorders,”
  43. (2001). The structure of the betacatenin/E-cadherincomplexandthemolecularbasisofdiverse ligand recognition by beta-catenin,”
  44. (2010). Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells,”